framycetin

This page covers all framycetin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Lecithin retinol acyltransferase, Menin, Transient receptor potential cation channel subfamily V member 1.

Targets

Lecithin retinol acyltransferase, Menin, Transient receptor potential cation channel subfamily V member 1

Phase 3 pipeline (1)

• Neomycin B · Other
  Neomycin B works by blocking the transient receptor potential cation channel subfamily V member 1, which is involved in various cellular processes.

Patent intelligence

• framycetin patent landscape — aggregated cliff calendar, attackable patents, originator estates